Clinical trial · NCT03747588 · RECRUITING · NA
The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
Sponsor: Peking Union Medical College Hospital
Summary
Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal procedures. Safety and feasibility remain controversial when comparing minimally-invasive with open pancreaticoduodenectomy, especially for malignant tumors.The aim of this study was to compare minimally invasive and open pancreatoduodenectomy for short-term outcomes and long-term follow-up in a randomized trial.
Interventions
- Minimally-invasive pancreaticoduodenectomy · PROCEDURE
Minimally-invasive pancreaticoduodenectomy for resection of pancreatic tumor
- Open pancreaticoduodenectomy · OTHER
Open pancreaticoduodenectomy for resection of pancreatic tumor
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Age: \>18yr, \<75yr * Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy * Preoperative imaging assessment is resectable or borderline resectable Exclusion Criteria: * Benign tumors of the head of pancreas * Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis. * conversion to laparotomy because of intraoperative difficulty
Sites (1)
- Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, Beijing Municipality, China · RECRUITING
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2022-10-03.